(MENAFN- EIN Presswire)
Gonadotropin-Releasing Hormone (GnRH) Agonist Global market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company's Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
You Can Now Pre Order Your Report To Get A Swift Deliver With All Your Needs” - The Business research company
LONDON, GREATER LONDON, UNITED KINGDOM, October 15, 2024 /EINPresswire / -- The gonadotropin-releasing hormone (GnRH) agonist market has grown steadily over recent years. It is expected to rise from $3.99 billion in 2023 to $4.1 billion in 2024, with a CAGR of 2.7%. Factors contributing to this growth include increased awareness and diagnosis of hormonal disorders, the rising prevalence of hormone-related diseases, higher rates of prostate cancer, growing demand for hormone therapy, and a focus on long-term safety and efficacy.
What Is The Estimated Market Size Of The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market And Its Annual Growth Rate?
The gonadotropin-releasing hormone (GnRH) agonist market is expected to experience steady growth, reaching $4.6 billion by 2028, with a CAGR of 2.9%. This anticipated growth is attributed to increased awareness and early diagnosis, rising healthcare expenditure, a growing application in fertility treatments, and heightened demand for personalized medicine. Major trends in this market include advancements in drug delivery systems, progress in oncology and reproductive medicine, and an increase in research and development efforts.
Explore Comprehensive Insights Into The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market With A Detailed Sample Report:
Growth Driver Of The Gonadotropin-Releasing Hormone (GnRH) Agonist Market
The rising incidence of hormone-related diseases is likely to drive the growth of the gonadotropin-releasing hormone (GnRH) agonist market in the future. Hormone-related disorders stem from imbalances or dysfunctions in the endocrine system, which produces and regulates hormones. These include conditions like diabetes, hyperthyroidism, and prostate cancer. The increasing prevalence of hormone-related diseases is attributed to environmental influences, obesity and metabolic syndrome, genetics, and an aging population. GnRH agonists are utilized to manage hormone levels effectively and provide a tailored approach to treating issues linked to hormonal imbalances and related diseases.
Explore The Report Store To Make A Direct Purchase Of The Report:
Which Market Players Are Driving The Gonadotropin-Releasing Hormone (GnRH) Agonist Market Growth?
Key players in the market include Pfizer Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Sandoz Group AG, Ipsen Pharma, Aurobindo Pharma Limited, Cipla Limited, Dr Reddy's Laboratories Ltd., Intas Pharmaceuticals Ltd., Ferring Pharmaceuticals, Amneal Pharmaceuticals Inc., Endo International plc, Lupin Limited, Gland Pharma Limited, Glenmark Pharmaceuticals Ltd., Zydus Lifesciences Limited, Bachem Holding AG, Tolmar Pharmaceuticals Inc., Debiopharm Group, Sun Pharmaceutical Industries Ltd.
What Are The Emerging Trends Shaping The Gonadotropin-Releasing Hormone (GnRH) Agonist Market Size ?
In the gonadotropin-releasing hormone (GnRH) agonist market, firms are developing advanced androgen deprivation therapy (ADT) drugs to improve treatment effectiveness for hormone-sensitive cancers. These drugs, including GnRH analogs, work by reducing or eliminating androgen levels, thereby slowing or halting the growth of hormone-sensitive tumors.
How Is The Global Gonadotropin-Releasing Hormone (GnRH) Agonist Market Segmented?
1) By Type: Leuprorelin, Goserelin, Taltirelin, Histrelin, Other Types
2) By Formulation: Injectable, Implants, Oral, Nasal Sprays
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By Application: Prostate Cancer, Breast Cancer, Endometriosis, Uterine Fibroids, Precocious Puberty, Fertility Treatment, Other Applications
5) By End-User: Hospital, Specialty Clinics, Ambulatory Surgical Centers (ASCs), Other End-Users
Geographical Insights: North America Leading The Gonadotropin-Releasing Hormone (GnRH) Agonist Market
North America was the largest region in the market in 2023. The regions covered in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Gonadotropin-Releasing Hormone (GnRH) Agonist Market Definition
Gonadotropin-releasing hormone (GnRH) agonists are synthetic agents that mimic natural GnRH, prompting the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These agonists are instrumental in managing hormonal imbalances and are particularly effective in fertility treatments by regulating hormone levels and preventing premature ovulation.
Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2024 from The Business Research Company covers the following information:
.Market size data for the forecast period: Historical and Future
.Macroeconomic factors affecting the market in the short and long run
.Analysis of the macro and micro economic factors that have affected the market in the past five years
.Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
.Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
An overview of the global gonadotropin-releasing hormone (GnRH) agonist market report covering trends, opportunities, strategies, and more
The Gonadotropin-Releasing Hormone (GnRH) Agonist Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on gonadotropin-releasing hormone (GnRH) agonist market size, gonadotropin-releasing hormone (GnRH) agonist market drivers and trends and gonadotropin-releasing hormone (GnRH) agonist market growth across geographies. This report helps you gain in-depth insights into opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Biosimilar Growth Hormones Global Market Report 2024
report/biosimilar-growth-hormone-global-market-report
Parathyroid Hormone Global Market Report 2024
report/parathyroid-hormones-global-market-report
Hormone Therapy Global Market Report 2024
report/hormone-therapy-global-market-report
What Does The Business Research Company Do?
The Business Research Company publishes over 15,000 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package, and much more.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
...
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MENAFN14102024003118003196ID1108778286